{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:48:30Z","timestamp":1789602510434,"version":"build-2803163510"},"reference-count":95,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1053\/j.seminoncol.2005.07.001","type":"journal-article","created":{"date-parts":[[2005,11,3]],"date-time":"2005-11-03T13:58:14Z","timestamp":1131026294000},"page":"479-487","source":"Crossref","is-referenced-by-count":62,"title":["Aberrant DNA Methylation in Cutaneous Malignancies"],"prefix":"10.1053","volume":"32","author":[{"given":"Remco","family":"van Doorn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelleke A.","family":"Gruis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rein","family":"Willemze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter A.","family":"van der Velden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis P.","family":"Tensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminoncol.2005.07.001_bib1","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/72785","article-title":"Aberrant CpG-island methylation has non-random and tumour-type-specific patterns","volume":"24","author":"Costello","year":"2000","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib2","first-page":"3225","article-title":"A gene hypermethylation profile of human cancer","volume":"61","author":"Esteller","year":"2001","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib3","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1126\/science.1083558","article-title":"Induction of tumors in mice by genomic hypomethylation","volume":"300","author":"Gaudet","year":"2003","journal-title":"Science"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib4","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1126\/science.1083557","article-title":"Chromosomal instability and tumors promoted by DNA hypomethylation","volume":"300","author":"Eden","year":"2003","journal-title":"Science"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1749-6632.2003.tb05960.x","article-title":"Hypomethylation","volume":"983","author":"Dunn","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib6","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1126\/science.1697983","article-title":"5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes","volume":"249","author":"Rideout","year":"1990","journal-title":"Science"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib7","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1093\/nar\/22.6.972","article-title":"The rate of hydrolytic deamination of 5-methylcytosine in double-stranded DNA","volume":"22","author":"Shen","year":"1994","journal-title":"Nucleic Acids Res"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib8","first-page":"4727","article-title":"Sunlight induces pyrimidine dimers preferentially at 5-methylcytosine bases","volume":"57","author":"Tommasi","year":"1997","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib9","doi-asserted-by":"crossref","first-page":"3814S","DOI":"10.1093\/jn\/132.12.3814S","article-title":"DNA methylation and diet in cancer","volume":"132","author":"Johanning","year":"2002","journal-title":"J Nutr"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1046\/j.0022-202x.2001.00048.x","article-title":"Human papillomavirus infection and skin cancer risk in organ transplant recipients","volume":"6","author":"Bouwes Bavinck","year":"2001","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib11","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1046\/j.1523-1747.2003.12246.x","article-title":"The influence of painful sunburns and lifetime sun exposure on the risk of actinic keratoses, seborrheic warts, melanocytic nevi, atypical nevi, and skin cancer","volume":"120","author":"Kennedy","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib12","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/096032718900800203","article-title":"Arsenic-induced skin toxicity","volume":"8","author":"Shannon","year":"1989","journal-title":"Hum Toxicol"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1023\/B:MCBI.0000007261.04684.78","article-title":"Molecular mechanisms of arsenic carcinogenesis","volume":"255","author":"Huang","year":"2004","journal-title":"Mol Cell Biochem"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib14","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/carcin\/bgh029","article-title":"Arsenic-induced DNA hypomethylation affects chromosomal instability in mammalian cells","volume":"25","author":"Sciandrello","year":"2004","journal-title":"Carcinogenesis"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1749-6632.2003.tb05970.x","article-title":"Epigenetics and the environment","volume":"983","author":"Sutherland","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib16","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0092-8674(00)81268-4","article-title":"Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome","volume":"85","author":"Hahn","year":"1996","journal-title":"Cell"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib17","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/ng0996-78","article-title":"The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas","volume":"14","author":"Gailani","year":"1996","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1011-1344(01)00199-3","article-title":"UV-induced DNA damage, repair, mutations and oncogenic pathways in skin cancer","volume":"63","author":"de Gruijl","year":"2001","journal-title":"J Photochem Photobiol B"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib19","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1126\/science.1073733","article-title":"Medulloblastoma growth inhibition by hedgehog pathway blockade","volume":"297","author":"Berman","year":"2001","journal-title":"Science"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib20","doi-asserted-by":"crossref","first-page":"5519","DOI":"10.1038\/sj.onc.1206854","article-title":"Analysis of 14-3-3sigma expression in hyperproliferative skin diseases reveals selective loss associated with CpG-methylation in basal cell carcinoma","volume":"22","author":"Lodygin","year":"2003","journal-title":"Oncogene"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib21","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/ajmg.c.30037","article-title":"The genetics of skin cancer","volume":"131C","author":"Tsai","year":"2004","journal-title":"Am J Med Genet"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib22","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/j.0022-202X.2004.22501.x","article-title":"p16INK4a and p14ARF tumor suppressor genes are commonly inactivated in cutaneous squamous cell carcinoma","volume":"122","author":"Brown","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib23","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/01.MP.0000077516.90063.7D","article-title":"Analysis of promoter hypermethylation of death-associated protein kinase and p16 tumor suppressor genes in actinic keratoses and squamous cell carcinomas of the skin","volume":"16","author":"Tyler","year":"2003","journal-title":"Mod Pathol"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib24","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.0022-202X.2004.23418.x","article-title":"Involvement of p53 and p16 tumor suppressor genes in recessive dystrophic epidermolysis bullosa-associated squamous cell carcinoma","volume":"123","author":"Arbiser","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib25","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1097\/01.MP.0000089779.35435.9D","article-title":"E-cadherin promoter hypermethylation in preneoplastic and neoplastic skin lesions","volume":"16","author":"Chiles","year":"2003","journal-title":"Mod Pathol"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib26","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.1158\/0008-5472.CAN-03-4061","article-title":"A mouse skin multistage carcinogenesis model reflects the aberrant DNA methylation patterns of human tumors","volume":"64","author":"Fraga","year":"2004","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/ng0994-22","article-title":"Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus","volume":"8","author":"Kamb","year":"1994","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib28","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nrc1145","article-title":"The genetics of malignant melanoma","volume":"3","author":"Chin","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib29","doi-asserted-by":"crossref","first-page":"5055","DOI":"10.1038\/sj.onc.1206809","article-title":"Both products of the mouse Ink4a\/Arf locus suppress melanoma formation in vivo","volume":"22","author":"Sharpless","year":"2003","journal-title":"Oncogene"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib30","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00008390-199506000-00005","article-title":"CDKN2 explains part of the clinical phenotype in Dutch familial atypical multiple-mole melanoma (FAMMM) syndrome families","volume":"5","author":"Gruis","year":"1995","journal-title":"Melanoma Res"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib31","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib32","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1023\/A:1026537423753","article-title":"An inducible melanoma model implicates a role for RAS in tumor maintenance and angiogenesis","volume":"19","author":"Wong","year":"2000","journal-title":"Cancer Metastasis Rev"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib33","first-page":"5336","article-title":"Low frequency of p16\/CDKN2A methylation in sporadic melanoma","volume":"57","author":"Gonzalgo","year":"1997","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib34","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1038\/sj.onc.1202803","article-title":"p16INK4a inactivation is not frequent in uncultured sporadic primary cutaneous melanoma","volume":"18","author":"Fujimoto","year":"1999","journal-title":"Oncogene"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib35","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0002-9440(10)64174-0","article-title":"Significant impact of promoter hypermethylation and the 540 C\u2192T polymorphism of CDKN2A in cutaneous melanoma of the vertical growth phase","volume":"161","author":"Straume","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib36","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1038\/sj.onc.1207505","article-title":"Profiling epigenetic inactivation of tumor suppressor genes in tumors and plasma from cutaneous melanoma patients","volume":"23","author":"Hoon","year":"2004","journal-title":"Oncogene"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib37","first-page":"5023","article-title":"Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma","volume":"56","author":"Flores","year":"1996","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib38","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/(SICI)1097-0215(19960315)65:6<762::AID-IJC9>3.0.CO;2-X","article-title":"Deletion mapping of chromosome region 9p21-p22 surrounding the CDKN2 locus in melanoma","volume":"65","author":"Ohta","year":"1996","journal-title":"Int J Cancer"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib39","first-page":"1639","article-title":"Epigenetic inactivation of RAS association domain family protein 1 (RASSF1A) in malignant cutaneous melanoma","volume":"63","author":"Spugnardi","year":"2003","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib40","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/ijc.11722","article-title":"Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas","volume":"109","author":"Reifenberger","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib41","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1515\/BC.2002.097","article-title":"Methylation of the RASSF1A gene in human cancers","volume":"383","author":"Pfeifer","year":"2002","journal-title":"Biol Chem"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib42","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1038\/sj.onc.1207647","article-title":"Genetic and epigenetic alterations of the APC gene in malignant melanoma","volume":"23","author":"Worm","year":"2004","journal-title":"Oncogene"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib43","first-page":"1415","article-title":"Epigenetic silencing of E- and P-cadherin gene expression in human melanoma cell lines","volume":"25","author":"Tsutsumida","year":"2004","journal-title":"Int J Oncol"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib44","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1242\/jcs.107.4.983","article-title":"E-cadherin is the major mediator of human melanocyte adhesion to keratinocytes in vitro","volume":"107","author":"Tang","year":"1994","journal-title":"J Cell Sci"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib45","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/35051606","article-title":"Inactivation of the apoptosis effector Apaf-1 in malignant melanoma","volume":"409","author":"Soengas","year":"2001","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib46","doi-asserted-by":"crossref","first-page":"7327","DOI":"10.1128\/MCB.19.11.7327","article-title":"DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter","volume":"19","author":"De Smet","year":"1999","journal-title":"Mol Cell Biol"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib47","doi-asserted-by":"crossref","first-page":"7149","DOI":"10.1073\/pnas.93.14.7149","article-title":"The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation","volume":"93","author":"De Smet","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib48","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00002371-200201000-00002","article-title":"Promoter methylation controls the expression of MAGE2, 3 and 4 genes in human cutaneous melanoma","volume":"25","author":"Sigalotti","year":"2002","journal-title":"J Immunother"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib49","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.0022-202X.2004.22308.x","article-title":"Aberrant expression of the maspin gene associated with epigenetic modification in melanoma cells","volume":"122","author":"Wada","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib50","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/(SICI)1097-0215(19960611)66:6<738::AID-IJC5>3.0.CO;2-0","article-title":"Infrequent expression of the MAGE gene family in uveal melanomas","volume":"66","author":"Mulcahy","year":"1996","journal-title":"Int J Cancer"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib51","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/ijc.11262","article-title":"Expression profiling reveals that methylation of TIMP3 is involved in uveal melanoma development","volume":"106","author":"van der Velden","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib52","first-page":"5303","article-title":"Promoter hypermethylation","volume":"61","author":"van der Velden","year":"2001","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib53","first-page":"354","article-title":"EORTC classification for primary cutaneous lymphomas","volume":"90","author":"Willemze","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib54","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1001\/jama.260.1.42","article-title":"Mycosis fungoides in the United States","volume":"260","author":"Weinstock","year":"1988","journal-title":"JAMA"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib55","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1001\/archderm.136.4.504","article-title":"Mycosis fungoides","volume":"136","author":"van Doorn","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib56","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1073\/pnas.92.12.5501","article-title":"Reduced surface expression of transforming growth factor beta receptor type II in mitogen-activated T cells from Sezary patients","volume":"92","author":"Capocasale","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib57","doi-asserted-by":"crossref","first-page":"6764","DOI":"10.1073\/pnas.94.13.6764","article-title":"Constitutive activation of a slowly migrating isoform of Stat3 in mycosis fungoides","volume":"94","author":"Nielsen","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib58","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0002-9440(10)65028-6","article-title":"p16(INK4a) gene alterations are frequent in lesions of mycosis fungoides","volume":"156","author":"Navas","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib59","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.0022-202x.2001.01682.x","article-title":"Frequent abnormalities of the p15 and p16 genes in mycosis fungoides and Sezary syndrome","volume":"118","author":"Scarisbrick","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib60","first-page":"5389","article-title":"A novel splice variant of the Fas gene in patients with cutaneous T-cell lymphoma","volume":"62","author":"van Doorn","year":"2002","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib61","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1182\/blood-2002-08-2434","article-title":"Amplification and overexpression of JUNB is associated with primary cutaneous T-cell lymphomas","volume":"101","author":"Mao","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib62","doi-asserted-by":"crossref","first-page":"5578","DOI":"10.1158\/0008-5472.CAN-04-1253","article-title":"Aberrant expression of the tyrosine kinase receptor EphA4 and the transcription factor Twist in Sezary syndrome identified by gene expression analysis","volume":"64","author":"van Doorn","year":"2004","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib63","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S1521-6616(03)00208-0","article-title":"Profiling aberrant DNA methylation in hematologic neoplasms","volume":"109","author":"Esteller","year":"2003","journal-title":"Clin Immunol"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib64","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1182\/blood.V98.9.2865","article-title":"Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma","volume":"98","author":"Piekarz","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib65","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1046\/j.1523-1747.2003.12496.x","article-title":"Microsatellite instability is associated with hypermethylation of the hMLH1 gene and reduced gene expression in mycosis fungoides","volume":"121","author":"Scarisbrick","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib66","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0002-9440(10)64629-9","article-title":"Lack of phosphotyrosine phosphatase SHP-1 expression in malignant T-cell lymphoma cells results from methylation of the SHP-1 promoter","volume":"157","author":"Zhang","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib67","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.1200\/JCO.2005.11.353","article-title":"Epigenetic profiling of cutaneous T-cell lymphoma","volume":"23","author":"Van Doorn","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib68","doi-asserted-by":"crossref","first-page":"4630","DOI":"10.1182\/blood-2003-06-2007","article-title":"SOCS1 and SHP1 hypermethylation in multiple myeloma","volume":"103","author":"Chim","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib69","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/sj.leu.2403385","article-title":"In vivo activation of STAT3 in cutaneous T-cell lymphoma","volume":"18","author":"Sommer","year":"2004","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib70","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1046\/j.1365-2133.2000.03471.x","article-title":"Primary cutaneous B-cell lymphoma","volume":"142","author":"Gronbaek","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib71","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1046\/j.1523-1747.2002.01785.x","article-title":"Inactivation of tumor suppressor genes p15(INK4b) and p16(INK4a) in primary cutaneous B cell lymphoma","volume":"118","author":"Child","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib72","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000064535","article-title":"Photocarcinogenesis","volume":"15","author":"de Gruijl","year":"2002","journal-title":"Skin Pharmacol Appl Skin Physiol"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib73","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.taap.2003.08.019","article-title":"Toxic effects of ultraviolet radiation on the skin","volume":"195","author":"Matsumura","year":"2004","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib74","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1365-4632.2004.02222.x","article-title":"Role of oxidative stress and the antioxidant network in cutaneous carcinogenesis","volume":"43","author":"Sander","year":"2004","journal-title":"Int J Dermatol"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib75","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1039\/b212664h","article-title":"Photophysical properties of 5-methylcytidine","volume":"2","author":"Sharonov","year":"2003","journal-title":"Photochem Photobiol Sci"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib76","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0027-5107(00)00022-1","article-title":"p53 mutational spectra and the role of methylated CpG sequences","volume":"450","author":"Pfeifer","year":"2000","journal-title":"Mutat Res"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib77","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.1073\/pnas.94.8.3893","article-title":"Cytosine methylation determines hot spots of DNA damage in the human P53 gene","volume":"94","author":"Denissenko","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib78","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1006\/jmbi.2000.4322","article-title":"Similarities in sunlight-induced mutational spectra of CpG-methylated transgenes and the p53 gene in skin cancer point to an important role of 5-methylcytosine residues in solar UV mutagenesis","volume":"305","author":"You","year":"2001","journal-title":"J Mol Biol"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib79","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S1476-5586(03)80039-8","article-title":"Exceptionally high protection of photocarcinogenesis by topical application of (\u2013)-epigallocatechin-3-gallate in hydrophilic cream in SKH-1 hairless mouse model","volume":"5","author":"Mittal","year":"2003","journal-title":"Neoplasia"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib80","first-page":"29","article-title":"Metabolic interference of melanogenesis in pigment cells","volume":"97","author":"Pavel","year":"1996","journal-title":"Sb Lek"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib81","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/humu.10179","article-title":"TP53 mutations in human skin cancers","volume":"21","author":"Giglia-Mari","year":"2003","journal-title":"Hum Mutat"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib82","first-page":"6579","article-title":"p53-mediated repression of DNA methyltransferase 1 expression by specific DNA binding","volume":"63","author":"Peterson","year":"2003","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib83","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/annonc\/mdg216","article-title":"A phase I pharmacokinetic and pharmacodynamic study of the DNA methyltransferase 1 inhibitor MG98 administered twice weekly","volume":"14","author":"Stewart","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib84","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1182\/blood-2003-03-0687","article-title":"Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2\u2032-deoxycytidine (decitabine) in hematopoietic malignancies","volume":"103","author":"Issa","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib85","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ccr.2004.06.023","article-title":"Preferential response of cancer cells to zebularine","volume":"6","author":"Cheng","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib86","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/01.LAB.0000025391.35798.F1","article-title":"Loss of T-cadherin (CDH13, H-cadherin) expression in cutaneous squamous cell carcinoma","volume":"82","author":"Takeuchi","year":"2002","journal-title":"Lab Invest"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib87","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1093\/hmg\/ddh298","article-title":"Epigenetic loss of the familial tumor-suppressor gene exostosin-1 (EXT1) disrupts heparan sulfate synthesis in cancer cells","volume":"13","author":"Ropero","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib88","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1158\/0008-5472.CAN-03-0164","article-title":"Hypermethylation and silencing of the putative tumor suppressor Tazarotene-induced gene 1 in human cancers","volume":"64","author":"Youssef","year":"2004","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib89","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1038\/modpathol.3800238","article-title":"Analysis of adenomatous polyposis coli gene expression, APC locus-microsatellite instability and APC promoter methylation in the progression of melanocytic tumours","volume":"17","author":"Korabiowska","year":"2004","journal-title":"Mod Pathol"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib90","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/ijc.11376","article-title":"ASC\/TMS1, a caspase-1 activating adaptor, is downregulated by aberrant methylation in human melanoma","volume":"107","author":"Guan","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib91","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0002-9440(10)63695-4","article-title":"Characterization of methylthioadenosin phosphorylase (MTAP) expression in malignant melanoma","volume":"163","author":"Behrmann","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib92","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/labinvest.3780405","article-title":"p16(INK4a) is selectively silenced in the tumoral progression of mycosis fungoides","volume":"82","author":"Navas","year":"2002","journal-title":"Lab Invest"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib93","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/j.1349-7006.2004.tb03184.x","article-title":"Promoter methylation profiling of 30 genes in human malignant melanoma","volume":"95","author":"Furuta","year":"2004","journal-title":"Cancer Sci"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib94","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00008390-200502000-00004","article-title":"Silencing of the thrombomodulin gene in human malignant melanoma","volume":"15","author":"Furuta","year":"2005","journal-title":"Melanoma Res"},{"key":"10.1053\/j.seminoncol.2005.07.001_bib95","first-page":"1401","article-title":"Methylation status of the p15, p16 and MGMT promoter genes in primary cutaneous T-cell lymphomas","volume":"89","author":"Gallardo","year":"2004","journal-title":"Haematologica"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009377540500268X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009377540500268X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T03:53:50Z","timestamp":1626666830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009377540500268X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":95,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S009377540500268X"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2005.07.001","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}